(Q35013676)

5 August 2017

title

Geometry of the randomized evidence for treatments of pulmonary hypertension (English)

1 reference

5 August 2017

1

1 reference

5 August 2017

3

John P A Ioannidis

0 references

author name string

Joe Zein

series ordinal

2

1 reference

5 August 2017

publication date

1 December 2013

1 reference

Cardiovascular Therapeutics

5 August 2017

published in

1 reference

5 August 2017

volume

31

1 reference

5 August 2017

issue

6

1 reference

5 August 2017

page(s)

e138-46

1 reference

Neglected tropical diseases: survey and geometry of randomised evidence

5 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4480770

Homophily and co-occurrence patterns shape randomized trials agendas: illustration in antifungal agents

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4480770

The need to consider the wider agenda in systematic reviews and meta-analyses: breadth, timing, and depth of the evidence

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4480770

Systematic review of trials using vasodilators in pulmonary arterial hypertension: why a new approach is needed

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4480770

Industry sponsorship and selection of comparators in randomized clinical trials

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4480770

Updated evidence-based treatment algorithm in pulmonary arterial hypertension.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4480770

Updated clinical classification of pulmonary hypertension.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4480770

ACCF/AHA 2009 expert consensus document on pulmonary hypertension: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association: developed in collaboration with the American Co

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4480770

A meta-analysis of randomized controlled trials in pulmonary arterial hypertension

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4480770

The ethics of randomized clinical trials in pulmonary arterial hypertension

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4480770

Evaluation of networks of randomized trials

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4480770

Why olanzapine beats risperidone, risperidone beats quetiapine, and quetiapine beats olanzapine: an exploratory analysis of head-to-head comparison studies of second-generation antipsychotics

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4480770

Sildenafil citrate therapy for pulmonary arterial hypertension

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4480770

Simultaneous comparison of multiple treatments: combining direct and indirect evidence.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4480770

Physicians' preferences for active-controlled versus placebo-controlled trials of new antihypertensive drugs

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4480770

Inhaled iloprost for severe pulmonary hypertension

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4480770

Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension: a double-blind, randomized, placebo-controlled trial.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4480770

Sildenafil versus Endothelin Receptor Antagonist for Pulmonary Hypertension (SERAPH) study

8 July 2018

1 reference

https://api.crossref.org/works/10.1111%2F1755-5922.12050

A randomised, controlled trial of bosentan in severe COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1755-5922.12050

Tadalafil therapy for pulmonary arterial hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1755-5922.12050

Ambrisentan for the treatment of pulmonary arterial hypertension: results of the ambrisentan in pulmonary arterial hypertension, randomized, double-blind, placebo-controlled, multicenter, efficacy (ARIES) study 1 and 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1755-5922.12050

Use of B-Type Natriuretic Peptide in the Risk Stratification of Acute Exacerbations of COPD

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1755-5922.12050

Bosentan therapy for pulmonary arterial hypertension

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24112824

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Treatment of primary pulmonary hypertension with continuous intravenous prostacyclin (epoprostenol). Results of a randomized trial

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24112824

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1111/1755-5922.12050

1 reference

5 August 2017

1 reference

5 August 2017

1 reference